“Comparing The Effect Of The SGLT-2 Inhibitors And DPP-4 Inhibitor Combined Therapy With Sulphonylureas And Metformin Combined Therapy In Patients With Type 2 Diabetic Nephropathy”, Journal of Pharmaceutical Negative Results, pp. 498–502, Jul. 2023, doi: 10.47750/pnr.2023.14.04.59.